Lincomycin Hcl

   
Google
 
Web NewDrugInformation.com

Lincomycin Hcl


Drug - Lincomycin Hcl
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Lincomycin Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - EQ 300MG BASE/ML
The potency of the active ingredient(s), Lincomycin Hydrochloride. May repeat for multiple part products.

Applicant - STERIS
The firm name holding legal responsibility for Lincomycin Hcl. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 063180
The FDA assigned number to Lincomycin Hcl. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Lincomycin Hcl. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Apr 16, 1991
The date Lincomycin Hcl was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Lincomycin Hcl. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Lincomycin Hcl is in. Format is RX, OTC, DISCN.

Applicant Full Name - Steris Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Lincomycin Hcl.

Lincomycin Hcl